News | July 27, 2025
Jagsonpal Pharmaceuticals Q1 FY26 revenue up 23.1%
Net profit doubled to Rs. 10.8 crore, with PAT margin expanding by 560 bps to 14.3%, reflecting strong operational execution
Net profit doubled to Rs. 10.8 crore, with PAT margin expanding by 560 bps to 14.3%, reflecting strong operational execution
To streamline complex medical writing workflows with GenAI
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
Ranks among the top 15% companies globally
Bayer expects 2025 to be the most difficult year of its turnaround
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
The introduction of Coveris’ sleeve-to-sleeve PCR model complements sectors such as bottling where an established recycling infrastructure exists
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Subscribe To Our Newsletter & Stay Updated
